Literature DB >> 2895123

Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene.

C L Verweij1, R Quadt, E Briët, K Dubbeldam, G B van Ommen, H Pannekoek.   

Abstract

Restriction fragment length polymorphisms (RFLPs), using the enzymes Bgl II and Xba I in conjunction with human von Willebrand factor (vWF) cDNA probes, have been described previously. In the present study we demonstrate the localization of both genetic markers within the vWF gene. The RFLPs were used to study the segregation of alleles associated with von Willebrand's disease (vWD) type IIA in a comprehensive, affected family. Individuals of this family were tested for their bleeding time and their plasma was analyzed for vWF antigen concentration and vWF ristocetin-cofactor activity. Based on these data, the affected members were diagnosed as vWD type-IIA patients; this conclusion was confirmed by the analysis of the multimeric vWF pattern of some of the patients. It was demonstrated that both RFLPs are completely linked with the vWD type-IIA trait. From this finding, we conclude that the defect that causes the vWD type IIA is most likely due to a mutation in the vWF gene and not to a mutation in a gene involved in posttranslational processing of the vWF protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2895123      PMCID: PMC329639          DOI: 10.1172/JCI113425

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  cDNA sequences for human von Willebrand factor reveal five types of repeated domains and five possible protein sequence polymorphisms.

Authors:  B B Shelton-Inloes; K Titani; J E Sadler
Journal:  Biochemistry       Date:  1986-06-03       Impact factor: 3.162

2.  Detection of single base substitutions by ribonuclease cleavage at mismatches in RNA:DNA duplexes.

Authors:  R M Myers; Z Larin; T Maniatis
Journal:  Science       Date:  1985-12-13       Impact factor: 47.728

3.  A polymorphism of the human von Willebrand factor (vWf) gene with BamHI.

Authors:  K Nishino; D C Lynch
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

4.  Amino acid sequence of human von Willebrand factor.

Authors:  K Titani; S Kumar; K Takio; L H Ericsson; R D Wade; K Ashida; K A Walsh; M W Chopek; J E Sadler; K Fujikawa
Journal:  Biochemistry       Date:  1986-06-03       Impact factor: 3.162

5.  RFLP for a human von Willebrand factor (vWF) cDNA clone, pvWF1100.

Authors:  C L Verweij; M Hofker; R Quadt; E Briet; H Pannekoek
Journal:  Nucleic Acids Res       Date:  1985-11-25       Impact factor: 16.971

6.  Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE).

Authors:  T S Zimmerman; J A Dent; Z M Ruggeri; L H Nannini
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

7.  Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II.

Authors:  P J Fay; Y Kawai; D D Wagner; D Ginsburg; D Bonthron; B M Ohlsson-Wilhelm; S I Chavin; G N Abraham; R I Handin; S H Orkin
Journal:  Science       Date:  1986-05-23       Impact factor: 47.728

8.  A polymorphic Xba I site within the human von Willebrand factor (vWF) gene identified by a vWF cDNA clone.

Authors:  R Quadt; C L Verweij; C J de Vries; E Briët; H Pannekoek
Journal:  Nucleic Acids Res       Date:  1986-09-11       Impact factor: 16.971

9.  Full-length von Willebrand factor (vWF) cDNA encodes a highly repetitive protein considerably larger than the mature vWF subunit.

Authors:  C L Verweij; P J Diergaarde; M Hart; H Pannekoek
Journal:  EMBO J       Date:  1986-08       Impact factor: 11.598

10.  Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor.

Authors:  D D Wagner; T Mayadas; V J Marder
Journal:  J Cell Biol       Date:  1986-04       Impact factor: 10.539

View more
  8 in total

1.  Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease.

Authors:  E W Murray; A R Giles; D Lillicrap
Journal:  Am J Hum Genet       Date:  1992-01       Impact factor: 11.025

2.  Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

Authors:  D Ginsburg; B A Konkle; J C Gill; R R Montgomery; P L Bockenstedt; T A Johnson; A Y Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

3.  Severe von Willebrand disease due to a defect at the level of von Willebrand factor mRNA expression: detection by exonic PCR-restriction fragment length polymorphism analysis.

Authors:  W C Nichols; S E Lyons; J S Harrison; R L Cody; D Ginsburg
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

4.  Analysis of the relationship of von Willebrand disease (vWD) and hereditary hemorrhagic telangiectasia and identification of a potential type IIA vWD mutation (IIe865 to Thr).

Authors:  M C Iannuzzi; N Hidaka; M Boehnke; M E Bruck; W T Hanna; F S Collins; D Ginsburg
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

5.  Inheritance and prevalence of von Willebrand's disease severe form in a Brazilian population.

Authors:  R R Fischer; C Lerner; E Bandinelli; A S Fonseca; I Roisenberg
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

6.  Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations.

Authors:  Jeffrey J Sutherland; Lee A O'Brien; David Lillicrap; Donald F Weaver
Journal:  J Mol Model       Date:  2004-08-03       Impact factor: 1.810

7.  Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity.

Authors:  M Anvret; M Blombäck; M Lindstedt; E Söderlind; M Tapper-Persson; A C Thelander
Journal:  Hum Genet       Date:  1992-05       Impact factor: 4.132

8.  Changes in thermodynamic stability of von Willebrand factor differentially affect the force-dependent binding to platelet GPIbalpha.

Authors:  Matthew Auton; Erik Sedlák; Jozef Marek; Tao Wu; Cheng Zhu; Miguel A Cruz
Journal:  Biophys J       Date:  2009-07-22       Impact factor: 4.033

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.